For Industry

Potential Over-the-Counter Monograph User Fees

Latest News:

A user fee program for nonprescription (over-the-counter or OTC) monograph drugs would be a potential funding mechanism to supplement congressional non user-fee appropriations, and would support timely and efficient FDA review of the efficacy and safety of ingredients included in or proposed for inclusion in a monograph. This website will be updated as further information on the development of a potential user fee program becomes available.

For questions relating to potential OTC monograph user fees, please email us at:
OTCMonographUserFeeProgram@fda.hhs.gov

 

Page Last Updated: 08/03/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English